Related CAS #
87-00-3 (free base); 51-56-9 (HBr)
Synonym
Homatropine hydrobromide; Homatropine-hydrobromide; Homatropini hydrobromidum; Homatropini-hydrobromidum; Homatropinum hydrobromicum; Homatropinum-hydrobromicum;
IUPAC/Chemical Name
(1R,3r,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-hydroxy-2-phenylacetate hydrobromide
InChi Key
DWSGTFTVBLXELC-RDYJJYPNSA-N
InChi Code
InChI=1S/C16H21NO3.BrH/c1-17-12-7-8-13(17)10-14(9-12)20-16(19)15(18)11-5-3-2-4-6-11;/h2-6,12-15,18H,7-10H2,1H3;1H/t12-,13+,14+,15?;
SMILES Code
CN1[C@@H]2CC[C@H]1C[C@@H](OC(C(c3ccccc3)O)=O)C2.Br
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
356.26
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. Homatropine. 2019 Oct 23. PMID: 30000723.
2: Fang L, Yu J, Jiang Z, Guo X. Preparation of a β-Cyclodextrin-Based Open- Tubular Capillary Electrochromatography Column and Application for Enantioseparations of Ten Basic Drugs. PLoS One. 2016 Jan 15;11(1):e0146292. doi: 10.1371/journal.pone.0146292. PMID: 26771454; PMCID: PMC4714747.
3: Sander BP, Collins MJ, Read SA. The effect of topical adrenergic and anticholinergic agents on the choroidal thickness of young healthy adults. Exp Eye Res. 2014 Nov;128:181-9. doi: 10.1016/j.exer.2014.10.003. Epub 2014 Oct 7. PMID: 25304219.
4: Zuo L, Meng H, Wu J, Jiang Z, Xu S, Guo X. Combined use of ionic liquid and β-CD for enantioseparation of 12 pharmaceuticals using CE. J Sep Sci. 2013 Feb;36(3):517-23. doi: 10.1002/jssc.201200824. Epub 2013 Jan 10. PMID: 23303483.
5: Cieri UR. Identification and estimation of the levo isomer in raw materials and finished products containing atropine and/or hyoscyamine. J AOAC Int. 2005 Jan-Feb;88(1):1-4. PMID: 15759719.
6: Millership JS. Interference of mandelic acid with the determination of homatropine hydrobromide by second-order derivative spectroscopy. J Pharm Biomed Anal. 1994 Sep;12(9):1199-203. doi: 10.1016/0731-7085(94)e0038-3. PMID: 7803572.
7: Arshinoff S, D'Addario D, Sadler C, Bilotta R, Johnson TM. Use of topical nonsteroidal anti-inflammatory drugs in excimer laser photorefractive keratectomy. J Cataract Refract Surg. 1994 Mar;20 Suppl:216-22. doi: 10.1016/s0886-3350(13)80756-0. PMID: 8006790.
8: Leung CP, Wong KC. Determination of homatropine hydrobromide in eye drops by second-order derivative spectroscopy. J Pharm Biomed Anal. 1991;9(2):195-8. doi: 10.1016/0731-7085(91)80145-y. PMID: 1873313.
9: Stojek A, Madejski J, Dedelis E, Janicki K. Usuwanie objawów późnego zespołu abstynencyjnego dospojówkowym podaniem 0.5% roztworu homatropiny (doniesienie wstepne) [Correction of the symptoms of late substance withdrawal syndrome by intra-conjunctival administration of 5% homatropine solution (preliminary report)]. Psychiatr Pol. 1990 May-Jun;24(3):195-201. Polish. PMID: 2084727.
10: Kay CD, Morrison JD. An evaluation of the effectiveness of intramuscular atropine or homatropine eyedrops in preventing the effects of physostigmine eyedrops on human vision. Q J Exp Physiol. 1988 Jul;73(4):511-9. doi: 10.1113/expphysiol.1988.sp003171. PMID: 3174912.
11: El-Nimr AE, Salama HA, Khalil RM, Kassem MA. Effect of urea on the activity of certain ophthalmic drugs in man. Pharmazie. 1983 Nov;38(11):728-30. PMID: 6689446.
12: Crom DB, Crom WR. Memo on medications: atropine sulfate and homatropine hydrobromide: common mydriatic/cycloplegic agents. J Ophthalmic Nurs Technol. 1982 Aug;1(2):38-40. PMID: 6980991.
13: Waller ES, Raebel MA. Relapsing polychondritis in a Latin American man. Am J Hosp Pharm. 1979 Jun;36(6):806-10. PMID: 463901.
14: Akopian OA. Fotometricheskoe opredelenie gomatropina gidrobromida v glaznykh kapliakh [Photometric determination of homatropine hydrobromide in eyedrops]. Farmatsiia. 1977 Jan-Feb;26(1):83-4. Russian. PMID: 576857.
15: Klíma M, Juran J, Klimová A. Zykloplegika und Residualakkommodation [Cycloplegia and residual accommodation (author's transl)]. Klin Monbl Augenheilkd. 1975 Jul;167(1):106-10. German. PMID: 1242785.
16: Homatropine bromhydrate d' [Homatropine hydrobromide]. Ann Pharm Fr. 1969 Mar;27(3):249-50. French. PMID: 5400247.
17: Chafetz L, Daly RE. Stability determination of homatropine hydrobromide by direct cerimetric titration. J Pharm Sci. 1968 Nov;57(11):1977-8. doi: 10.1002/jps.2600571132. PMID: 5725932.
18: CHRISTENSEN RE, PEARCE I. HOMATROPINE HYDROBROMIDE. EFFECT OF TOPICAL ADMINISTRATION UPON THE INTRAOCULAR PRESSURE AND AQUEOUS FACILITY VALUES OF NORMAL AND CHRONIC SIMPLE GLAUCOMATOUS EYES. Arch Ophthalmol. 1963 Sep;70:376-80. doi: 10.1001/archopht.1963.00960050378019. PMID: 14048800.
19: SAVANKO OM, RESHETNIAK VA. [Use of a 4 per cent solution of homatropine hydrobromide for the determination of refraction in young patients]. Vestn Oftalmol. 1963 Mar-Apr;76:72-4. Russian. PMID: 13986875.
20: MUELLER WH, DEARDORFF DL. Ophthalmic vehicles: the effect of methylcellulose on the penetration of homatropine hydrobromide through the cornea. J Am Pharm Assoc Am Pharm Assoc. 1956 May;45(5):334-41. doi: 10.1002/jps.3030450518. PMID: 13319125.
